Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study
Ilaria Cetta(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Roberta Messina(Vita-Salute San Raffaele University), Laura Zanandrea(Vita-Salute San Raffaele University), Bruno Colombo(Vita-Salute San Raffaele University)
Cited by 27
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k